These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37293832)

  • 1. Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature.
    Mortier C; Quintelier K; De Craemer AS; Renson T; Deroo L; Dumas E; Verheugen E; Coudenys J; Decruy T; Lukasik Z; Van Gassen S; Saeys Y; Hoorens A; Lobatón T; Van den Bosch F; Van de Wiele T; Venken K; Elewaut D
    Arthritis Rheumatol; 2023 Nov; 75(11):1969-1982. PubMed ID: 37293832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Blood Mucosal-Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal-Associated Invariant T Cells From the Axial Entheses of Non-Axial Spondyloarthritis Control Patients.
    Rosine N; Rowe H; Koturan S; Yahia-Cherbal H; Leloup C; Watad A; Berenbaum F; Sellam J; Dougados M; Aimanianda V; Cuthbert R; Bridgewood C; Newton D; Bianchi E; Rogge L; McGonagle D; Miceli-Richard C
    Arthritis Rheumatol; 2022 Nov; 74(11):1786-1795. PubMed ID: 35166073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.
    Venken K; Jacques P; Mortier C; Labadia ME; Decruy T; Coudenys J; Hoyt K; Wayne AL; Hughes R; Turner M; Van Gassen S; Martens L; Smith D; Harcken C; Wahle J; Wang CT; Verheugen E; Schryvers N; Varkas G; Cypers H; Wittoek R; Piette Y; Gyselbrecht L; Van Calenbergh S; Van den Bosch F; Saeys Y; Nabozny G; Elewaut D
    Nat Commun; 2019 Jan; 10(1):9. PubMed ID: 30602780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ILC3 in Axial Spondyloarthritis: the Gut Angle.
    Mauro D; Macaluso F; Fasano S; Alessandro R; Ciccia F
    Curr Rheumatol Rep; 2019 Jun; 21(7):37. PubMed ID: 31197599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.
    Reinhardt A; Prinz I
    Front Immunol; 2018; 9():885. PubMed ID: 29922283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
    Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
    J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function.
    Min HK; Na HS; Jhun J; Lee SY; Choi SS; Park GE; Lee JS; Um IG; Lee SY; Seo H; Shin TS; Kim YK; Lee JJ; Kwok SK; Cho ML; Park SH
    Front Immunol; 2023; 14():1096565. PubMed ID: 37143677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal Inflammation.
    Manasson J; Wallach DS; Guggino G; Stapylton M; Badri MH; Solomon G; Reddy SM; Coras R; Aksenov AA; Jones DR; Girija PV; Neimann AL; Heguy A; Segal LN; Dorrestein PC; Bonneau R; Guma M; Ciccia F; Ubeda C; Clemente JC; Scher JU
    Arthritis Rheumatol; 2020 Apr; 72(4):645-657. PubMed ID: 31729183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation
    Chen S; van Tok MN; Knaup VL; Kraal L; Pots D; Bartels L; Gravallese EM; Taurog JD; van de Sande M; van Duivenvoorde LM; Baeten DL
    Front Immunol; 2019; 10():2344. PubMed ID: 32194539
    [No Abstract]   [Full Text] [Related]  

  • 12. Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content.
    Chen S; Noordenbos T; Blijdorp I; van Mens L; Ambarus CA; Vogels E; Te Velde A; Alsina M; Cañete JD; Yeremenko N; Baeten D
    Rheumatology (Oxford); 2019 Apr; 58(4):617-627. PubMed ID: 30517745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.
    Pedersen SJ; Maksymowych WP
    Drugs; 2018 Sep; 78(14):1397-1418. PubMed ID: 30171593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice.
    Benham H; Rehaume LM; Hasnain SZ; Velasco J; Baillet AC; Ruutu M; Kikly K; Wang R; Tseng HW; Thomas GP; Brown MA; Strutton G; McGuckin MA; Thomas R
    Arthritis Rheumatol; 2014 Jul; 66(7):1755-67. PubMed ID: 24664521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.
    Van Praet L; Van den Bosch FE; Jacques P; Carron P; Jans L; Colman R; Glorieus E; Peeters H; Mielants H; De Vos M; Cuvelier C; Elewaut D
    Ann Rheum Dis; 2013 Mar; 72(3):414-7. PubMed ID: 23139267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities.
    Jansen DT; Hameetman M; van Bergen J; Huizinga TW; van der Heijde D; Toes RE; van Gaalen FA
    Rheumatology (Oxford); 2015 Apr; 54(4):728-35. PubMed ID: 25288779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity.
    Kragstrup TW; Andersen T; Holm C; Schiøttz-Christensen B; Jurik AG; Hvid M; Deleuran B
    Clin Exp Immunol; 2015 May; 180(2):233-42. PubMed ID: 25639337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
    McGonagle D; Watad A; Sharif K; Bridgewood C
    Front Immunol; 2021; 12():614255. PubMed ID: 33815371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.
    Van Damme N; De Vos M; Baeten D; Demetter P; Mielants H; Verbruggen G; Cuvelier C; Veys EM; De Keyser F
    Ann Rheum Dis; 2001 May; 60(5):495-9. PubMed ID: 11302872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.
    Triggianese P; Conigliaro P; Chimenti MS; Biancone L; Monteleone G; Perricone R; Monteleone I
    Clin Exp Rheumatol; 2016; 34(6):1085-1093. PubMed ID: 27782868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.